Document Preview Unavailable

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)

Sheng, Calvin C; Sahoo, Debasis; Dugar, Siddharth; Prada, Robier Aguillon; Wang, Tom Kai Ming; et al.  Clinical Cardiology Vol. 43, Iss. 10,  (Oct 2020): 1055-1063.

You might have access to this document